Cannabis Meets Adaptogens: The Functional Wellness Blends Taking Over in 2026
Advertisement
Walk into any forward-thinking dispensary or wellness shop in 2026, and you'll notice something new on the shelves: cannabis products that don't just contain THC or CBD, but layer in adaptogens like ashwagandha, nootropics like lion's mane mushroom, and botanicals like lemon balm and passionflower. The era of "just get high" is giving way to something more deliberate — functional cannabis formulations designed to target specific outcomes like focus, calm, sleep, or recovery. And the market is responding with explosive growth.
Key Takeaways
- The global relaxation beverage market is projected to reach $21.6 billion by 2030, with cannabinoid-adaptogen blends among the fastest-growing segments
- Leading brands like Brēz ($50M+ revenue), Trip ($100M in 2025), and Hiyo are combining THC/CBD with ashwagandha, lion's mane, and L-theanine
- Cannabis-adaptogen wellness blends are one of the fastest-growing product categories in 2026, driven by consumer demand for targeted functional effects
Table of Contents
- The Convergence: Why Cannabis and Adaptogens Are Merging Now
- The Brands Leading the Charge
- The Science Behind the Stacks
- What Consumers Should Know
The Convergence: Why Cannabis and Adaptogens Are Merging Now
The convergence of cannabis and functional wellness has been building for years, but 2026 is the year it went mainstream. Several forces are driving the merger.
First, consumer expectations have evolved. Today's cannabis buyer — particularly among the Millennial and Gen Z demographics — doesn't just want a product that works. They want one that fits into a broader wellness routine alongside their morning smoothie, their yoga practice, and their evening wind-down ritual.
Cannabis is no longer a category unto itself; it's becoming an ingredient in a larger functional wellness toolkit.
Second, the "sober curious" movement and the broader trend of alcohol replacement have created a massive consumer segment looking for something beyond traditional cannabis or traditional supplements. These consumers want products that deliver relaxation, sociability, or mood enhancement without alcohol's calories, hangover, or health risks. Cannabis-adaptogen blends occupy this sweet spot perfectly.
Third, the science has matured enough to give formulators confidence. Adaptogens like ashwagandha and rhodiola have decades of clinical research supporting their stress-modulating effects. Nootropics like L-theanine (the calming amino acid in green tea) and lion's mane mushroom (studied for its nerve-growth-factor stimulation) have similarly robust evidence bases.
Combining these researched ingredients with cannabinoids creates products that can tell a more compelling — and more credible — wellness story.
The Brands Leading the Charge
The functional cannabis-wellness space is attracting both cannabis-native companies and wellness brands crossing into the cannabinoid world.
Brēz has emerged as one of the fastest-growing players, with projected 2025 revenue exceeding $50 million and momentum carrying into 2026. The brand's product lines illustrate the strategy: Amplify and Drift combine 5mg THC with adaptogens for a low-dose social experience, while the THC/CBD-free Elevate (caffeine and lion's mane for focus) and Dream (chamomile and mushrooms for sleep) extend the brand into the broader functional beverage market. Brēz is now available at Sprouts Farmers Market locations nationwide.
Trip, founded by husband-and-wife team Daniel Khoury and Olivia Ferdi, hit $100 million in revenue in 2025 and is projected to double that figure in 2026. Originally a CBD-focused brand, Trip's formulations now feature magnesium, lion's mane, ashwagandha, and L-theanine. The brand has expanded to over 15,000 U.S. retail locations and 50,000 globally, with a recent Cherry Lemon variety launching at Whole Foods Market.
Hiyo, based in Venice, California, markets what it calls "The Float" — a stress-relieving, mood-boosting sensation achieved through a functional stack of 1.7 grams of adaptogens and nootropics per serving. The formula includes L-theanine, lion's mane, ashwagandha, lemon balm, passionflower, and ginger. CEO Evan Quinn positions the brand explicitly as an alcohol alternative, with the name standing for "Happy In Your Own."
Recess, the brand that helped pioneer the adaptogen-beverage category in 2017 with hemp-derived CBD sparkling water, has evolved its product line to include Recess Mood — a sparkling water featuring magnesium and adaptogens formulated for cognitive function. The brand's pivot illustrates how regulatory uncertainty around CBD has pushed some companies toward adaptogen-forward formulations.
In the cannabis-specific space, brands like BLNCD Naturals are producing THC gummies with adaptogen blends designed for specific use cases: brain boosting for focus and energy, calm blends for anxiety relief, and sleep formulations for nighttime use. These products are available through licensed dispensaries in legal states and represent the next evolution of the cannabis edible category.
The Science Behind the Stacks
The appeal of cannabis-adaptogen blends isn't just marketing — there's a pharmacological logic to the combinations.
Ashwagandha, classified as an adaptogen for its ability to modulate the body's stress response, has been shown in clinical trials to reduce cortisol levels by up to 30%. When combined with CBD, which interacts with the endocannabinoid system [Quick Definition: Your body's built-in network of receptors that interact with cannabinoids] to promote homeostasis, the two compounds may work through complementary pathways to address stress and anxiety.
Lion's mane mushroom stimulates the production of nerve growth factor (NGF), a protein essential for brain cell maintenance and regeneration. Pairing it with low-dose THC — which some users report enhances creativity and associative thinking — creates a "focus stack" that appeals to the growing demographic of cannabis microdosers who use small amounts during work or creative activities.
L-theanine, which promotes alpha brain wave activity associated with calm alertness, pairs naturally with both THC and CBD. The amino acid's ability to take the edge off THC's psychoactive effects while maintaining its mood-enhancing properties makes it one of the most common ingredients in functional cannabis formulations.
The functional mushroom category more broadly — including reishi for immune support, cordyceps for energy, and chaga for antioxidant protection — is experiencing its own boom. Global projections place the relaxation beverage market at $21.6 billion by 2030, growing at an 8.1% compound annual growth rate, with adaptogen and cannabinoid blends representing one of the fastest-growing subsegments.
What Consumers Should Know
For consumers navigating the emerging world of cannabis-adaptogen products, a few practical considerations are worth keeping in mind.
Dosing matters more with combination products. The interaction between cannabinoids and other active ingredients means that the effective dose for a blend may differ from what you're used to with a standalone THC or CBD product. Starting low and going slow is even more important when multiple active compounds are involved.
Quality and transparency vary widely. Look for products that provide third-party lab testing not just for cannabinoid content but for the adaptogens and nootropics as well. Ashwagandha potency, for example, depends on its withanolide concentration, and not all products standardize to the same level.
Regulation is still catching up. In most states, cannabis products sold through dispensaries are tested for cannabinoid content, pesticides, and heavy metals, but the adaptogen and nootropic ingredients in those same products may not be subject to the same scrutiny. Products sold as hemp-derived beverages outside of dispensaries face even less oversight.
Despite these caveats, the trajectory is clear. Cannabis is moving from a standalone intoxicant category toward integration with the broader functional wellness market. For consumers who approach these products thoughtfully, the expanding options represent a genuine evolution in how cannabis fits into daily life.
Pull-Quote Suggestions:
"Brēz is now available at Sprouts Farmers Market locations nationwide.
Trip, founded by husband-and-wife team Daniel Khoury and Olivia Ferdi, hit $100 million in revenue in 2025 and is projected to double that figure in 2026."
"Global projections place the relaxation beverage market at $21.6 billion by 2030, growing at an 8.1% compound annual growth rate, with adaptogen and cannabinoid blends representing one of the fastest-growing subsegments."
"The functional cannabis-wellness space is attracting both cannabis-native companies and wellness brands crossing into the cannabinoid world.
Brēz has emerged as one of the fastest-growing players, with projected 2025 revenue exceeding $50 million and momentum carrying into 2026."
Why It Matters: From THC + ashwagandha gummies to CBD + lion's mane drinks, cannabis-adaptogen wellness blends are booming. Explore the brands, ingredients, and science behind the trend.